The first known case of subacute thyroiditis after COVID-19 infection has been reported in a study published in The Journal of Clinical Endocrinology & Metabolism.
Jay Sibbitts, Shu Jia, Obdulia Covarrubias-Zambrano, Stefan H. Bossmann and Christopher T Culbertson from Kansas State University’s Department of Chemistry walk us through what we need to know about microfluidic devices for detecting pain.
Philippe JACQUES, Managing Director of EMIRI, explores how advanced materials can be used to solve global challenges such as the current COVID-19 pandemic.
Aarthi Janakiraman, Research Manager, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explores if nanotechnology aids the battle against COVID-19.
Prashant Dogra1, Kavya Sinha2, Zhihui Wang1, Vittorio Cristini1,*
1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas
2Department of Cardiovascular Surgery, Houston Methodist DeBakey Heart...
Researchers from The University of Manchester, Salford Royal and Res Consortium prove that over 25% of the UK are likely to have contracted COVID-19 already.
Here, Megan Warrender looks into the strides being made by the NIDCR to support dental research and innovation, and, in particular, how current initiatives feed into long term plans for dental, oral and craniofacial health and disease in the U.S.
One of the key questions is soon to be answered by researchers, who will track lockdown impact on alcohol intake, gambling habits and porn watching.
Here, R.M Winglee and M. Danner, Department of Earth and Space Sciences, University of Washington, discuss robotic exploration and High-Velocity Impactors.
Studies suggest that the use of mesenchymal stem cells collected from umbilical cord blood and tissue are a safe and effective way to alleviate symptoms of coronavirus and promote fast recovery.
The Division of Chemistry at the National Science Foundation, provides an update on their work in driving discovery and development concerning chemistry research that improves the quality of life in the United States.
Researchers say we should repurpose existing drugs, which would be faster than waiting for a "magic bullet" vaccine to treat COVID-19.
Mike Fischer CBE, Founder of the COVID-19 Volunteer Testing Network, details the work being done to keep healthcare workers safe on the frontline and provide regular screening for COVID-19.
Scientists at TCS designed novel chemical compounds using AI that can inhibit the 3CL protease of SARS-CoV-2, which is responsible for viral replication. Ananth Krishnan, Chief Technology Office, TCS, discusses the research here.
Several drugs used for curing hepatitis C have been identified as potential candidates to treat COVID-19, according to research conducted using the MOGON II supercomputer at Johannes Gutenberg University Mainz.
Daniel Berman, Head of Global Health, Nesta Challenges, says that it should not have taken COVID-19 to emphasise the necessity of rapid testing.
Researchers studying coronavirus cases in China have found that Cytokine storms and T cell counts may offer clues on how to treat COVID-19.
Study finds non-white, low-income populations suffer increased COVID-19 death risk, and proposes rent freeze policies to help people survive.
Dr Anas Nader, co-founder of Patchwork Health, discusses the crucial role UK healthtech startups are playing on the frontline of the NHS COVID-19 response.
The University of Barcelona explain to the world how to build a ventilator inexpensively, which functions like a high-quality commercial device.